The New Idea Award application process will open September 2015.
The Leukemia & Lymphoma Society (LLS) is in its third year of The New Idea Award, a grant program designed to identify novel research strategies with high potential for high impact on the future of blood cancer treatment(s). Specifically, this program supports academic researchers with innovative ideas for approaches that are substantially different from standard therapies and prognostic/diagnostic modalities, as well as ideas that may fundamentally change our understanding of blood cancer(s). Successful awards will describe potentially paradigm-shifting ideas that take research in a substantially new direction, and thus preliminary data is not required. In order to receive such an award, applicants must succinctly describe the innovative idea/approach and a method for testing it in one aim, within the one year grant period, capped at $75,000.